Mark J. Vignola - 31 May 2023 Form 4 Insider Report for Terns Pharmaceuticals, Inc. (TERN)

Role
Chief Financial Officer
Signature
/s/ Bryan Yoon, as Attorney-in-Fact for Mark J. Vignola
Issuer symbol
TERN
Transactions as of
31 May 2023
Net transactions value
+$14,096
Form type
4
Filing time
02 Jun 2023, 17:03:34 UTC
Previous filing
03 Feb 2023
Next filing
04 Dec 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TERN Common Stock Purchase $14,096 +9,997 +131% $1.41* 17,656 31 May 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes the purchase of 9,997 shares under the Terns Employee Stock Purchase Plan on May 31, 2023.

Remarks:

Voluntary reporting of ESPP purchase